4.7 Article

MiR-153 reduces stem cell-like phenotype and tumor growth of lung adenocarcinoma by targeting Jagged1

Related references

Note: Only part of the references are listed.
Article Oncology

Cancer Statistics, 2018

Rebecca L. Siegel et al.

CA-A CANCER JOURNAL FOR CLINICIANS (2018)

Correction Oncology

miR-153 suppresses IDO1 expression and enhances CAR T cell immunotherapy (vol 11, 58, 2018)

Qian Huang et al.

JOURNAL OF HEMATOLOGY & ONCOLOGY (2018)

Article Biochemistry & Molecular Biology

HOXC8 regulates self-renewal, differentiation and transformation of breast cancer stem cells

Mansi Shah et al.

MOLECULAR CANCER (2017)

Article Oncology

Lung cancer stem cells: The root of resistance

Lauren MacDonagh et al.

CANCER LETTERS (2016)

Review Oncology

MicroRNA as Regulators of Cancer Stem Cells and Chemoresistance in Colorectal Cancer

Xiaoming Liu et al.

CURRENT CANCER DRUG TARGETS (2016)

Article Multidisciplinary Sciences

JAG1 Is Associated with Poor Survival through Inducing Metastasis in Lung Cancer

Wen-Hsin Chang et al.

PLOS ONE (2016)

Review Pharmacology & Pharmacy

Role of microRNAs in maintaining cancer stem cells

Michela Garofalo et al.

ADVANCED DRUG DELIVERY REVIEWS (2015)

Article Biochemistry & Molecular Biology

MiR-153 inhibits migration and invasion of human non-small-cell lung cancer by targeting ADAM19

Nianxi Shan et al.

BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2015)

Article Cell & Tissue Engineering

MicroRNA-153 Regulates the Acquisition of Gliogenic Competence by Neural Stem Cells

Jun Tsuyama et al.

STEM CELL REPORTS (2015)

Article Oncology

Suppression of AKT expression by miR-153 produced anti-tumor activity in lung cancer

Ye Yuan et al.

INTERNATIONAL JOURNAL OF CANCER (2015)

Review Biochemistry & Molecular Biology

Targeting cancer stem cells to suppress acquired chemotherapy resistance

S. J. Vidal et al.

ONCOGENE (2014)

Review Oncology

Non-small-cell lung cancers: a heterogeneous set of diseases

Zhao Chen et al.

NATURE REVIEWS CANCER (2014)

Article Biochemistry & Molecular Biology

Aberrant microRNAs Expression in CD133+/CD326+ Human Lung Adenocarcinoma Initiating Cells from A549

Sheng Lin et al.

MOLECULES AND CELLS (2012)

Article Oncology

Lung Cancer Stem Cells as a Target for Therapy

Elieser Gorelik et al.

ANTI-CANCER AGENTS IN MEDICINAL CHEMISTRY (2010)

Review Biochemistry & Molecular Biology

EMT, cancer stem cells and drug resistance: an emerging axis of evil in the war on cancer

A. Singh et al.

ONCOGENE (2010)

Article Multidisciplinary Sciences

Highly tumorigenic lung cancer CD133+ cells display stem-like features and are spared by cisplatin treatment

Giulia Bertolini et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2009)

Article Biochemistry & Molecular Biology

Identification and expansion of the tumorigenic lung cancer stem cell population

A. Eramo et al.

CELL DEATH AND DIFFERENTIATION (2008)

Review Endocrinology & Metabolism

Cell and molecular biology of Notch

Ulla-Maj Fiuza et al.

JOURNAL OF ENDOCRINOLOGY (2007)

Review Oncology

MicroRNA signatures in human cancers

George A. Calin et al.

NATURE REVIEWS CANCER (2006)

Article Cell Biology

The MicroRNA pathway plays a regulatory role in stem cell division

HR Shcherbata et al.

CELL CYCLE (2006)

Review Cell Biology

Notch signalling: a simple pathway becomes complex

Sarah J. Bray

NATURE REVIEWS MOLECULAR CELL BIOLOGY (2006)

Review Biochemistry & Molecular Biology

MicroRNAs: Genomics, biogenesis, mechanism, and function

DP Bartel

Review Multidisciplinary Sciences

Stem cells, cancer, and cancer stem cells

T Reya et al.

NATURE (2001)